Sign In
Buy CPRX
$31.49
+0 (+0%)
At Close: Jul 31, 2026
Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards?
12:36pm, Monday, 04'th May 2026
CPRX's Q1 earnings are expected to beat estimates on strong Firdapse demand and rising Agamree sales, while Fycompa faces patent-driven pressure.
Catalyst Pharmaceutical (CPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:06am, Monday, 04'th May 2026
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Monday, 04'th May 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
08:03am, Tuesday, 28'th Apr 2026
The Company will Host a Conference Call and Webcast on May 12, 2026, at 8:30 AM ET The Company will Host a Conference Call and Webcast on May 12, 2026, at 8:30 AM ET
NVS SMA Drug Gets CHMP Backing, Malaria Drug Wins WHO Prequalification
01:20pm, Monday, 27'th Apr 2026
Novartis secures CHMP backing for Itvisma in SMA and wins WHO nod for Coartem Baby, targeting critical gaps in rare disease and infant malaria care.
Catalyst (CPRX) is on the Move, Here's Why the Trend Could be Sustainable
09:55am, Monday, 27'th Apr 2026
Catalyst (CPRX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our s
Strength Seen in Catalyst (CPRX): Can Its 6.7% Jump Turn into More Strength?
05:06am, Friday, 24'th Apr 2026
Catalyst (CPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
CPRX or UTHR: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 20'th Apr 2026
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and United Therapeutics (UTHR). But which of these two stocks is more attractive to val
Head-To-Head Survey: Aptorum Group (NASDAQ:APM) versus Catalyst Pharmaceuticals (NASDAQ:CPRX)
01:11am, Thursday, 16'th Apr 2026
Aptorum Group (NASDAQ: APM - Get Free Report) and Catalyst Pharmaceuticals (NASDAQ: CPRX - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two b
Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?
10:56am, Wednesday, 15'th Apr 2026
The mean of analysts' price targets for Catalyst (CPRX) points to a 28.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analyst
See How Institutions Boost Catalyst Shares
07:33am, Wednesday, 15'th Apr 2026
Shares of Catalyst Pharmaceuticals, Inc. (CPRX) up 148% since 2022's first outlier institutional inflow signal.
Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why
09:57am, Thursday, 09'th Apr 2026
Catalyst (CPRX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our
CPRX or UTHR: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 03'rd Apr 2026
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Catalyst Pharmaceutical (CPRX) and United Therapeutics (UTHR). But which of these two stocks offers value
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
11:01am, Thursday, 02'nd Apr 2026
Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, CPRX, TBPH, RLMD and AVTX may prove to be good additions to one's portfolio.
New Strong Buy Stocks for March 31st
06:31am, Tuesday, 31'st Mar 2026
EFXT, CPRX, GEV, STRA and BP have been added to the Zacks Rank #1 (Strong Buy) List on March 31st, 2026.
